Venus Concept Inc. (NASDAQ:VERO) shares fell on Wednesday after the company said it will voluntarily delist from Nasdaq and end SEC reporting.
The board notified Nasdaq that it plans to leave the Nasdaq Capital Market and deregister with the SEC, citing compliance costs that outweigh the benefits of staying listed.
As of September 30, 2025, the company's inventories totaled $15.768 million. Cash and equivalents totaled $4.312 million.
Where And When It Happens
Venus Concept said it plans to file a Form 25 with the SEC on or about January 30, 2026.
The company expects its last day of trading on Nasdaq to be on or about February 6, 2026.
The company also plans to file a Form 15 on or about February 9, 2026. That filing will immediately suspend its obligation to submit periodic SEC reports, including Forms 10-K, 10-Q and 8-K.
The board said it reviewed the cost of ongoing SEC reporting and determined it exceeds the value of remaining publicly listed.
"The Board of Directors, after thorough evaluation, has determined this action is in the best interests of the Company and its shareholders," said Rajiv De Silva, chief executive officer of Venus Concept.
He said the company will continue working with Madryn Asset Management to support long-term financial success.
Venus Concept sells medical aesthetic technology, including minimally invasive and non-invasive devices, in more than 60 countries.
Its portfolio includes Venus NOVA, Venus Versa and the ARTAS iX robotic hair restoration system.
VERO Price Action: Venus Concept shares were down 54.83% at $2.00 at the time of publication on Wednesday. The stock is near its 52-week low of $1.39, according to Benzinga Pro data.
Image via Shutterstock
